正在為您準備內容...
正在為您準備內容...
成份 · Ingredient
利拉利汀
利拉利汀是一種二肽基肽酶-4（DPP-4）抑制劑，屬於黃嘌呤衍生物。主要用於治療第二型糖尿病，通過抑制DPP-4酶來增加腸促胰素的活性，從而改善血糖控制。
Linagliptin is a xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes. It has a role as a hypoglycemic agent and an EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor. It is a member of quinazolines and an aminopiperidine. It is functionally related to a 7H-xanthine.
| 藥品名稱 | 成份 | 號碼 |
|---|---|---|
| EUROLINA FILM-COATED TABLETS 5MG | HK-68952 | |
| GLYXAMBI TABLETS 10MG/5MG | HK-65353 | |
| GLYXAMBI TABLETS 25MG/5MG | HK-65354 | |
| LINAGLIPTIN FPH TABLETS 5MG | HK-68415 | |
| LINAGLIPTIN SANDOZ TABLETS 5MG | HK-68353 | |
| LINAGLIPTIN TAISHO TABLETS 5MG | HK-68588 | |
| TRAJENTA DUO TAB 2.5/1000MG | HK-61967 | |
| TRAJENTA DUO TAB 2.5/850MG | HK-61966 | |
| TRAJENTA DUO TABLETS 2.5/500MG | HK-62327 | |
| TRAJENTA FILM COATED TABLET 5MG | HK-61383 | |
| TRESOLUS TABLETS 5MG | HK-68715 |
藥品資料來源：香港衞生署藥物辦公室 · 化學資料來源：PubChem (NIH) · 資料僅供參考，不構成醫療建議